Chronic hyperglycemia leads to glucose auto-oxidation and excessive ROS production, overwhelming the antioxidant defense system and disrupting redox homeostasis [107,108,109,110,111]
Safe, fast, effective
For patients researching GLP-1 weight loss, medical weight loss, semaglutide, or tirzepatide, the most important question is not simply, Which medication causes the most weight loss? A better question is: Which medically supervised approach is appropriate for my health history, body composition, metabolic risk, side-effect tolerance, and long-term maintenance plan
Key Findings from the Clinical Trial The study, led by Christian Hendershot at USC's Institute for Addiction Science, showed that weekly injections of semaglutide compared to placebo: Reduced alcohol cravings significantly Decreased drinking quantity overall Lowered the frequency of heavy drinking days What makes these results particularly exciting is that the magnitude of semaglutide's effects appeared potentially greater than what is typically seen with existing FDA-approved medications for alcohol use disorder, even though the drug was only administered at the lowest clinical doses
Gastroenterology & Hepatology, 21(3), 172179
_edited.jpg)
